Erschienen in:
01.10.2013 | Original Article
22q11.2 Deletions in Patients with Conotruncal Defects: Data from 1,610 Consecutive Cases
verfasst von:
Shabnam Peyvandi, Philip J. Lupo, Jennifer Garbarini, Stacy Woyciechowski, Sharon Edman, Beverly S. Emanuel, Laura E. Mitchell, Elizabeth Goldmuntz
Erschienen in:
Pediatric Cardiology
|
Ausgabe 7/2013
Einloggen, um Zugang zu erhalten
Abstract
The 22q11.2 deletion syndrome is characterized by multiple congenital anomalies including conotruncal cardiac defects. Identifying the patient with a 22q11.2 deletion (22q11del) can be challenging because many extracardiac features become apparent later in life. We sought to better define the cardiac phenotype associated with a 22q11del to help direct genetic testing. 1,610 patients with conotruncal defects were sequentially tested for a 22q11del. The counts and frequencies of primary lesions and cardiac features were tabulated for those with and those without a 22q11del. Logistic regression models investigated cardiac features that predicted deletion status in tetralogy of Fallot (TOF). Deletion frequency varied by primary anatomic phenotype. Regardless of the cardiac diagnosis, a concurrent aortic arch anomaly (AAA) was strongly associated with deletion status [odds ratio (OR), 5.07; 95 % confidence interval (CI), 3.66–7.04]. In the TOF subset, the strongest predictor of deletion status was an AAA (OR, 3.14; 95 % CI 1.87–5.27; p < 0.001), followed by pulmonary valve atresia (OR, 2.03; 95 % CI 1.02–4.02; p = 0.04). Among those with double-outlet right ventricle and transposition of the great arteries, only those with an AAA had a 22q11del. However, 5 % of the patients with an isolated conoventricular ventricular septal defect and normal aortic arch anatomy had a 22q11del, whereas no one with an interrupted aortic arch type A had a 22q11del. A subset of patients with conotruncal defects are at risk for a 22q11del. A concurrent AAA increases the risk regardless of the intracardiac anatomy. These findings help to direct genetic screening for the 22q11.2 deletion syndrome in the cardiac patient.